Search

Author/Creator Fischer von Weikersthal, L

1. 124PAssociation of microRNA-21 (miR-21) with efficacy of cetuximab (cet) and bevacizumab (bev) in patients with metastatic colorectal cancer (mCRC) within the FIRE-3 study (AIO KRK-0306). (23rd October 2018)

Authors:
Miller-Phillips, L; Fischer von Weikersthal, L; Kaiser, F; Al-Batran, S-E; Heintges, T; Neureiter, D; Kahl, C; Kullmann, F; Moehler, M; Scheithauer, W; Vazart, C; Fontaine, K; Held, S; Modest, D P; Neumann, J; Jung, A; Kirchner, T; Heinemann, V; Stintzing, S
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1508TiPDurvalumab in frail and elder patients with stage four NSCLC: The DURATION trial. (23rd October 2018)

Authors:
Kuon, J; Bozorgmehr, F; Schneider, M A; Krisam, J; Lasitschka, F; Serke, M; Schuette, W; Moosmann, N; Gleiber, W; Faehling, M; Wermke, M; Schuett, P; Boesche, M; van Laak, V; Fischer von Weikersthal, L; Ulmer, M; Meyer zum Büschenfelde, C; Fischer, J R; Thomas, M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial. (14th November 2019)

Authors:
Stintzing, S; Wirapati, P; Lenz, H -J; Neureiter, D; Fischer von Weikersthal, L; Decker, T; Kiani, A; Kaiser, F; Al-Batran, S; Heintges, T; Lerchenmüller, C; Kahl, C; Seipelt, G; Kullmann, F; Moehler, M; Scheithauer, W; Held, S; Modest, D P; Jung, A; Kirchner, T
Journal:
Annals of oncology
Issue:
Volume 30:Number 11(2019)
Page Start:
1796
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search